Michael Gallant

Michael E. Gallant, Esquire

Attorney Gallant manages the firm’s pharmaceutical and medical device department. Michael received his law degree from Catholic University of America in 1995. He is a member of the New York Bar since 1995 and the District of Columbia Bar since 1996.

Before joining Bernheim Dolinsky Kelley, LLC, Attorney Gallant managed the pharmaceutical and medical device practice of Pollack & Flanders, LLP. Prior thereto he was a partner of Ashcraft & Gerel, LLP, and Herman, Mathis, Casey, Kitchens & Gerel, LLP.

Mr. Gallant has spent his career assisting thousands of clients injured by defective medical devices and pharmaceutical products. He has been instrumental in pursuing litigation concerning the diet drugs Fen-Phen and Redux®, silicone gel breast implants, the gastroesophageal reflux medication Propulsid, the hormone replacement therapy Prempro™, the Ortho Evra Birth Control Patch, Guidant Internal Cardiac Defibrillators.

Today, Attorney Gallant is investigating and prosecuting claims for injuries arising out of the use of the diabetes drug Avandia, Depuy Orthopedic’s ASR Hip Replacement Systems, Zimmer Nexgen Knee Replacement Systems, Medtronic Infuse bone morphogenic protein (BMP) and the anti-coagulant drug Pradaxa.

Mr. Gallant is actively involved in professional organizations such as the American Association for Justice, the D.C. Bar Association, the New York Bar Association and the Trial Lawyers Association of Metropolitan Washington, D.C.